Brown et al. [123] showed that antigen-presenting DCs express GPR81, whose lactate-mediated activation suppresses the cell-surface expression of MHC-II, thereby compromising the ability of DCs to present tumor-cell antigens to T cells [123]. The gene discussed is HCAR1; the disease is neoplasm.